- Home
- MYFW vs ACIU Comparison
MYFW vs ACIU Comparison
Compare MYFW & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYFW | ACIU |
|---|---|---|
| Founded | 2002 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.7M | 289.0M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MYFW | ACIU |
|---|---|---|
| Price | $27.64 | $2.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $26.50 | $10.00 |
| AVG Volume (30 Days) | 20.7K | ★ 246.7K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.02 | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $96,914,000.00 | N/A |
| Revenue This Year | $20.48 | $706.75 |
| Revenue Next Year | $9.70 | $321.13 |
| P/E Ratio | $20.84 | ★ N/A |
| Revenue Growth | ★ 7.60 | N/A |
| 52 Week Low | $20.10 | $1.60 |
| 52 Week High | $28.00 | $4.00 |
Technical Indicators
Market Signals| Indicator | MYFW | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 62.81 | 48.96 |
| Support Level | $22.04 | $2.56 |
| Resistance Level | $28.00 | $2.99 |
| Average True Range (ATR) | 0.67 | 0.18 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 77.12 | 25.00 |
Price Performance
Historical ComparisonAbout MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.